Carlisle P. Landel Ph.D.

Director, Custom Animal Model Division

Transposagen Biopharmaceuticals

Lexington, KY

www.transposagenbio.com

clandel@transposagenbio.com

Transposagen Biopharmaceuticals, Inc., a Lexington, KY-based company, is a worldwide leader in technologies and services for genetic modification. Transposagen is dedicated to providing better disease models through genetic modification. Transposagen specializes in custom and off-the-shelf XTN™ site-specific nucleases, animal models, cell lines, stem cells and cutting-edge research tools and technologies to improve drug discovery and development research. These unique technologies and services for genetic modification give customers the ability to create nearly any genetic modification in any genome for both research and protein production purposes.

Thursday March 28, 2013

4:00pm

116 THM

sponsored by Department of Biology Ribble Endowment

Host: Ed Rucker

*Refreshments served at 3:45